Narva clinics has been acquired by Narva Åderbråckscenter AB

The founder and some key employees of Åderbråcksspecialisterna Narva Kirurg Center AB and Narva Derma Center AB (Narva) have completed an MBO.

Åderbråcksspecialisterna Narva Kirurg Center and Narva Derma Center are engaged in varicose vein treatments and aesthetic skincare. Founded in 2012, Narva is a leading Swedish pioneer in modern endovenous treatments for varicose veins. Most of its income comes from private paying patients but Narva is also one of only two market players contracted by the region of Stockholm to carry out varicose vein treatments. Based in Stockholm, Narva also operates several clinics around the country.

Narva Åderbråckscenter AB is a newly created company owned by Narva’s founder together with key employees. The new shareholders will develop Narva’s business plan in order to take advantage of the market opportunities within privately funded healthcare.

Oaklins’ team in Sweden acted as financial advisor in this transaction.

Service

M&A sell-side

Parties

“Together with Oaklins’ team in Sweden, we have carefully worked through the various strategic options at hand for a change of ownership in Narva. The team’s financial and strategic expertise, as well as their experience in the healthcare sector, have been crucial when evaluating the various alternatives.”

Stefan Nydahl

Founder, Narva Åderbråckscenter AB

Talk to the deal team

Adel Koubaa

Managing Partner

Stockholm, Sweden
Oaklins Sweden

View profile Get in touch

Lars Gustafsson

Partner

Stockholm, Sweden
Oaklins Sweden

View profile Get in touch

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more

Rare Patient Voice has been acquired by Konovo

Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more